Arca Biopharma, Inc.
ABIO
Revenue
0.00
0.000.00%
12 Months ChangeAssets
33.84M
▼-2.86M▼-7.80%
3 Months ChangeLiabilities
1.27M
▼-310.00k▼-19.61%
3 Months ChangeFree Cash Flow
-4.30M
▲931.00k▲17.80%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-04-25
Form 8-K
ID: 0000950170-24-048364
2024-04-25
Form 10-Q
ID: 0000950170-24-048329
2024-04-23
Form 8-K
ID: 0000950170-24-046918
2024-04-04
Form 8-K
ID: 0000950170-24-041846
2024-04-03
Form 8-K
ID: 0001193125-24-085437
2024-03-22
Form 8-K
ID: 0000950170-24-035373
2024-02-06
Form 8-K
ID: 0000950170-24-011737
2024-02-01
Form 8-K
ID: 0000950170-24-009852
2024-01-31
Form 8-K
ID: 0000950170-24-009397
2023-12-05
Form 8-K
ID: 0000950170-23-068189